Interactions between HMR 3647, a new ketolide, and human polymorphonuclear neutrophils

Antimicrobial Agents and Chemotherapy

Volumn 42, Issue 8, 1998, Pages 1944-1951

  Vazifeh, D ^a   Preira, A ^a   Bryskier, A ^b   Labro, M T ^a  

^a BICHAT HOSPITAL   (France)

^b SANOFI   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AMPICILLIN; ANTIBIOTIC AGENT; AZITHROMYCIN; ERYTHROMYCIN; ERYTHROMYCIN DERIVATIVE; JOSAMYCIN; KETOLIDE; MACROLIDE; ROXITHROMYCIN; SUPEROXIDE; TELITHROMYCIN; UNCLASSIFIED DRUG;

ARTICLE; CELL VIABILITY; DRUG ACCUMULATION; DRUG ACTIVATION; DRUG EFFECT; DRUG SCREENING; DRUG TISSUE LEVEL; DRUG UPTAKE; HUMAN; HUMAN CELL; INCUBATION TIME; MICHAELIS CONSTANT; POLYMORPHONUCLEAR CELL; PRIORITY JOURNAL; STRUCTURE ACTIVITY RELATION;

EID: 0031879813     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.42.8.1944     Document Type: Article

References (36)

1. Abdelghaffar, H., D. Vazifeh, and M. T. Labro. 1997. Erythromycin A-derived macrolides modify the functional activities of human neutrophils by altering the phospholipase D-phosphatidate phosphohydrolase transduction pathway. J. Immunol. 159:3995-4005.
2. Abdelghaffar, H., and M. T. Labro. 1996. Effect of RU 64004 on oxidant production by human neutrophils, abstr. F-225, p. 139. In Program and abstracts of the 36th Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology, Washington, D.C.
3. Abdelghaffar, H., E. M. Mtairag, and M. T. Labro. 1994. Effects of dirithromycin and erythromycylamine on human neutrophil degranulation. Antimicrob. Agents chemother. 38:1548-1554.
4. Agouridas, C., A. Bonnefoy, and J. F. Chantot. 1997. In vitro antibacterial activity of HMR 3647, a novel ketolide highly active against respiratory pathogens, ahstr. F-112, p. 165. In Program and abstracts of the 37th Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology, Washington, D.C.
5. Araujo-Khan, F., A. Bryskier, and J. Remington. 1997. Ketolides are active against Toxoplasma gondii, abstr. F-251, p. 188. In Program and abstracts of the 37th Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology, Washington, D.C.
6. Arceci, R. J., K. Stieglitz, and B. E. Bierer. 1992. Immunosuppressants FK506 and rapamycin function as reversal agents of the multidrug resistance phenotype. Blood 80:1528-1536.
7. Bergmeyer, H. U., and E. Bernt. 1963. Lactate dehydrogenase, p. 737-739. In H. U. Bergmeyer (ed.), Methods in enzymatic analysis. Academic Press, Inc., New York, N.Y.
8. Bryskier, A., C. Agouridas, and J. F. Chantot. 1997. Ketolides: new semisynthetic 14-membered-ring macrolides, p. 39-50. In S. H. Zinner, L. S. Young, J. F. Acar, and H. C. Neu (ed.), Expanding indications for the new macrolides, azalides, and streptogramins. Marcel Dekker, Inc., New York, N.Y.
9. Crosta, L., V. Candiloro, M. Meli, M. Tolomeo, L. Rausa, and L. Dusonchet. 1994. Lacidipine and josamycin: two new multidrug resistance modulators. Anticancer Res. 14:2685-2690.
10. 2+ changes, cyclic AMP and protein kinase C. Biochim. Biophys. Acta 845:223-236.
11. Endicott, J. A., and V. Ling. 1989. The biochemistry of P-glycoprotein-mediated multidrug resistance. Annu. Rev. Biochem. 58:137-171.
12. Fontagne, J., M. Roch-Arveiller, J. P. Giroux, and P. Lechat. 1989. Effects of some antimalarials on rat inflammatory polymorphonuclear leukocyte function. Biomed. Pharmacother. 43:43-51.
13. Hand, W. L., N. King-Thompson, and J. W. Holman. 1987. Entry of roxithromycin (RU 965), imipenem, cefotaxime, trimethoprim, and metronidazole into human polymorphonuclear leukocytes. Antimicrob. Agents Chemother. 31:1553-1557.
14. Henry, P. D. 1980. Comparative pharmacology of calcium antagonists: nifedipine, verapamil and diltiazem. Am. J. Cardiol. 46:1047-1058.
15. Koga, H. 1987. High-performance liquid chromatography measurement of antimicrobial concentrations in polymorphonuclear leukocytes. Antimicrob. Agents Chemother. 30:137-142.
16. Labro, M. T. 1993. Effect of macrolides on host natural defenses, p. 389-408. In A. Bryskier, J. P. Butzler, H. C. Neu, and P. M. Tulkens (ed.), Macrolides: chemistry, pharmacology and clinical use. Arnette-Blackwell, Paris, France.
17. Labro, M. T. 1993. Intraphagocytic penetration of macrolide antibiotics, p. 379-388. In A. Bryskier, J. P. Butzler, H. C. Neu, and P. M. Tulkens (ed.), Macrolides: chemistry, pharmacology and clinical use. Arnette-Blackwell, Paris, France.
18. Labro, M. T. 1996. Immunomodulatory action of antibacterial agents. Clin. Immunother. 6:454-464.
19. Labro, M. T. 1996. Intracellular bioactivity of macrolides. Clin. Microbiol. Infect. 1(Suppl. 1):24-30.
20. Labro, M. T., and C. Babin-Chevaye. 1988. Effects of amodiaquine, chloroquine, and mefloquine on human polymorphonuclear neutrophil function in vitro. Antimicrob. Agents Chemother. 32:1124-1130.
21. Labro, M. T., H. Abdelghaffar, and H. Kirst. 1997. Structure-activity relationships among erythromycylamine derivatives for their effects on human neutrophils in vitro, abstr. F-268, p. 191. In Program and abstracts of the 37th Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology, Washington, D.C.
22. Labro, M. T., and J. El Benna. 1991. Effect of monodesethyl amodiaquine on human polymorphonuclear leukocyte functions in vitro. Antimicrob. Agents Chemother. 35:824-830.
23. Labro, M. T., D. Vazifeh, and H. Abdelghaffar. 1997. Effect of the new ketolide HMR 3647 on human neutrophil function in vitro, abstr. F-257, p. 189. In Program and abstracts of the 37th Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology, Washington, D.C.
24. Labro, M. T., H. Abdelghaffar, D. Vazifeh, and A. Bryskier. 1996. Roxithromycin uptake by human neutrophils is mediated by a protein kinase A-dependent mechanism, abstr. 110-018, p. 278. In Program and abstracts of the 7th International Congress for Infectious Diseases.
25. Labro, M. T. 1997. Effects of macrolides on leukocytes and inflammation, p. 101-116. In S. H. Zinner, L. S. Young, and J. F. Acar (ed.), Expanding indications of the new macrolides, azalides and streptogramins. Marcel Dekker, Inc., New York, N.Y.
26. Laufen, H., A. Wildfeuer, and P. Lach. 1989. Kinetics of the uptake of antimicrobial agents by human polymorphonuclear leucocytes. Arzneim. Forsch. 39:233-235.
27. Laufen, H., A. Wildfeuer, and P. Lach. 1990. Mechanism of azithromycin uptake in human polymorphonuclear leucocytes. Arzneim. Forsch. 40:686-689.
28. Litwack, G. 1955. Photometric determination of lysozyme activity. Proc. Soc. Exp. Biol. Med. 89:401-403.
29. Mtairag, E. M., H. Abdelghaffar, and M. T. Labro. 1994. Investigation of dirithromycin and erythromycylamine uptake by human neutrophils in vitro. J. Antimicrob. Chemother. 33:523-536.
30. Mtairag, E. M., H. Abdelghaffar, C. Douhet, and M. T. Labro. 1995. Role of extracellular calcium in in vitro uptake and intraphagocytic location of macrolides Antimicrob. Agents Chemother. 39:1676-1682.
31. Roblin, P. M., and M. R. Hammerschlag. 1997. In vitro activity of a new ketolide antibiotic, HMR 3647, against Chlamydia pneumoniae, abstr. F-248, p. 188. In Program and abstracts of the 37th Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology, Washington, D.C.
32. Smith, R. P., A. L. Baltch, W. Ritz, M. Franke, and P. Michelsen. 1997. Antibacterial effect of ketolides HMR3004 and HMR3647 against intracellular Legionella pneumophila, abstr. F-249, p. 188. In Program and abstracts of the 37th Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology, Washington, D.C.
33. Styrt, B., and M. S. Klempner. 1986. Inhibition of neutrophil oxidative metabolism by lysomotropic weak bases. Blood 67:334-342.
34. Talalay, P., W. H. Fishman, and C. Huggins. 1946. Chromogenic substrate. II. Phenolphthalein glucuronic acid as substrate for the assay of glucuronidase activity. J. Biol. Chem. 166:756-772.
35. Vazifeh, D., H. Abdelghaffar, and M. T. Labro. 1997. Cellular accumulation of the new ketolide RU 64004 by human neutrophils: comparison with that of azithromycin and roxithromycin. Antimicrob. Agents Chemother. 41: 2099-2107.
36. Vazifeh, D., A. Bryskier, and M. T. Labro. 1997. Investigation of the mechanism underlying levofloxacin uptake by human neutrophils, abstr. A-74, p. 15. In Program and abstracts of the 37th Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology, Washington, D.C.